Skip to content

Clinical trials

Mucopolysaccharidosis III trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20102
20111
20124
20131
20143
20153
20162
20172
20184
20192
20203
20211
20222
20233
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Recruiting5
Unknown status4
Active, not recruiting3
Enrolling by invitation3
Not yet recruiting2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allievex Corporation5
Shire4
Alexion Pharmaceuticals, Inc.3
Phoenix Nest3
Ultragenyx Pharmaceutical Inc3
Abeona Therapeutics, Inc2
Masonic Cancer Center, University of Minnesota2
Swedish Orphan Biovitrum2
University of Minnesota2
Albert Einstein College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III43
Mucopolysaccharidoses10
Leukodystrophy, Globoid Cell7
Lysosomal Storage Diseases7
Leukodystrophy, Metachromatic6
Mucopolysaccharidosis II6
Mucopolysaccharidosis I5
Mucopolysaccharidosis VI5
Sandhoff Disease5
Sudden Infant Death5

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.